Iontophoresis Drug Delivery Electrodes | pH-Buffered | Bulk OEM
Address pH drift and skin burns in iontophoresis drug delivery. These disposable electrodes are designed to maintain ion migration consistency under active DC load.
Why These Patches Fail (It's Not the Drug)
Most teams assume the problem is the formulation. In reality, it's usually the interface.
You run a stable drug in a vial. You load it into a patch. Twenty minutes later - irritation, unstable delivery, failed data. Same drug, different outcome. What changed? The electrochemical environment.
Iontophoresis isn't just "apply current." It's forcing a reaction system to stay stable while you're actively breaking water apart. If the electrode isn't designed for that, it doesn't matter how good your API is. Most issues don't come from the total surface area - but from how much of that area stays chemically stable during delivery.
What Actually Goes Wrong (And When It Shows Up)
Most failures don't show up at the start. They show up mid-session. That's why a lot of lab tests miss them.
① pH Drift - The Silent Failure
You won't see this in the first 5 分钟. Everything looks fine. Then the ions start building up. Anode becomes acidic; cathode becomes alkaline.
If there's no real buffering system inside the patch, the interface starts shifting. Not gradually - abruptly. That's when patients report: "It's not shocking… it's burning." That's not electrical. That's chemistry.
② Reservoir Breakdown (The Ignored Part)
Looks stable when dry. Changes completely when loaded. We've seen reservoirs:
- Soften after saturation
- Shift under slight movement
- Create micro air gaps
Once that happens, the current path becomes unstable, delivery becomes uneven, and impedance starts drifting. And none of that shows up in basic spec sheets.
③ Drug Pooling (Where Design Shortcuts Show)
If the material isn't tuned correctly, liquid doesn't distribute evenly. It collects in certain zones. Current follows that path, not your design. Result: * Localized high current density.
- Uneven delivery.
- Irritation that gets blamed on the drug.
What We Actually Control in Production
We don't treat these as "pads." We treat them as controlled delivery interfaces.
- Reservoir behavior matters more than size: We work with non-woven or gel-based matrices that hold saturation without collapsing or leaking during use.
- pH stability isn't theoretical: We track it under continuous DC load, not just static conditions. Most "good samples" fail here because they can't handle the long-duration chemical shift.
- Adhesion for wet conditions: Dry adhesion numbers don't mean much once the reservoir is loaded. We focus on keeping the structure intact under full saturation.
- Impedance over time: What matters is whether the impedance stays stable 20–40 分钟 into the session.
Where Most of the Work Actually Happens
It's not in cutting shapes. It's in controlling the chemistry batch-to-batch.
Buffering layers are the hardest part to keep consistent. A small variation in raw materials leads to a big shift under DC load. That's why most "good samples" from small shops don't scale; production exposes the instability.
We split manufacturing between China and Vietnam for logistics. But the core challenge is still the same: keeping the electrochemical behavior consistent, not just the physical shape.
If You're Seeing These Problems
Then it's usually not your formulation. It's the interface.
👉 [Request Samples for pH Drift Testing]
Hot Tags: disposable drug delivery iontophoresis electrode, China disposable drug delivery iontophoresis electrode manufacturers, suppliers, factory, dexamethasone for iontophoresis patch, iomed patch, ionto pads, iontophoresis cortisone patch, Iontophoresis Pad, Iontophoresis Patches







